Yesseinia Angleró-Rodríguez

Senior Scientist at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Yesseinia Angleró-Rodríguez's Colleagues at Alnylam Pharmaceuticals
Hadrien Kitabgi Khan

Senior Director, Head of Finance - Global R&D and Pipeline Strategy

Contact Hadrien Kitabgi Khan

Femi Adeduji

Principal Associate Scientist

Contact Femi Adeduji

Mike Struharik

Preclinical Study Manager

Contact Mike Struharik

Eric Pérez

Sr. Category Manager - Commercial, Medical Affairs and G&A

Contact Eric Pérez

Brian Van

Sr Manager Facility Systems

Contact Brian Van

Melody Thompson

Sr. Manager, Nonclinical Writing

Contact Melody Thompson

Kevin Dooley

Associate Director, Research

Contact Kevin Dooley

View All Yesseinia Angleró-Rodríguez's Colleagues
Yesseinia Angleró-Rodríguez's Contact Details
HQ
(617) 551-8200
Location
Cambridge, Massachusetts, United States
Company
Alnylam Pharmaceuticals
Yesseinia Angleró-Rodríguez's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Yesseinia Angleró-Rodríguez
Yesseinia Angleró-Rodríguez currently works for Alnylam Pharmaceuticals.
Yesseinia Angleró-Rodríguez's role at Alnylam Pharmaceuticals is Senior Scientist.
Yesseinia Angleró-Rodríguez's email address is ***@alnylam.com. To view Yesseinia Angleró-Rodríguez's full email address, please signup to ConnectPlex.
Yesseinia Angleró-Rodríguez works in the SaaS industry.
Yesseinia Angleró-Rodríguez's colleagues at Alnylam Pharmaceuticals are Hadrien Kitabgi Khan, Femi Adeduji, Mike Struharik, Eric Pérez, Brian Van, Melody Thompson, Kevin Dooley and others.
Yesseinia Angleró-Rodríguez's phone number is (617) 551-8200
See more information about Yesseinia Angleró-Rodríguez